Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial.

Trial Profile

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 May 2016

At a glance

  • Drugs Rabeprazole (Primary) ; Teprenone
  • Indications Duodenal ulcer; Gastric ulcer; NSAID-induced ulcer
  • Focus Registrational; Therapeutic Use
  • Acronyms Planetarium
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 28 Nov 2013 Results published in the Media Release.
    • 28 Nov 2013 Primary endpoint 'Disease-recurrence-rate' has been met.
    • 28 Nov 2013 Status changed from recruiting to completed (parent trial; NCT01397448).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top